ALDX Aldeyra Therapeutics, Inc. logo

ALDX Aldeyra Therapeutics, Inc.

Healthcare
$1.55-2.52%ClosedMarket Cap: $93.5M

As of 2026-05-25

Insider Statistics (Q1 2026)

Acquisitions

2

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+75,000

Shares Acquired

75,000

Shares Disposed

0

Total Bought ($)

$2.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue Mar 31Brady Todd Cdirector, officer: President and CEOSell1,880,510$1.771,880,510
Tue Mar 31Brady Todd Cdirector, officer: President and CEOSell632,318$0.00632,318
Fri Mar 20DOUGLAS RICHARDdirectorBuy70,000$1.40195,000
Thu Mar 19Alfieri Michaelofficer: Principal Financial OfficerBuy5,000$1.427,500
Fri Aug 15Alfieri Michaelofficer: Principal Financial OfficerBuy2,500$5.302,500
Wed Aug 13Machatha Stephenofficer: Chief Development OfficerSell22,073$5.15221,799
Thu Jun 12Walker NealdirectorSell62,728$2.6962,728
Thu Jun 12Walker NealdirectorSell2,413$2.692,413
Thu Jun 12Miller-Rich NancydirectorSell62,728$2.6962,728
Thu Jun 12Miller-Rich NancydirectorSell2,413$2.692,413
Thu Jun 12Bronstein BendirectorSell62,728$2.6962,728
Thu Jun 12Bronstein BendirectorSell3,860$2.693,860